News

The U.S. FDA has expanded approved use of Vertex Pharmaceuticals manufactured Kalydeco (ivacaftor) for treating cystic fibrosis. The approval triples the number of rare gene mutations…
Read More...

The U.S. FDA has granted Octapharma with orphan drug designation for Octagam 10%. Octagam 10% is an immune globulin intravenous (human) liquid for the treatment of…
Read More...

Cogstate Ltd announced that Eli Lilly’s has selected Cogstate as preferred provider for Alzheimer’s Disease Platform, to support with solutions to ensure high-quality neuropsychological…
Read More...

Concert Pharmaceuticals received notice from the U.S. FDA that its CTP-543 Phase 2a clinical trial for alopecia areata has been placed on clinical hold. The FDA had previously…
Read More...

CytoDyn In. announced the treatment of the first patient suffering from GvHD(Graft versus Host Disease) with use of PRO 140 during its clinical trial Phase 2. The multicenter,…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that USFDA has approved to launch Doxorubicin Hydrochloride Liposome Injection for intravenous use, in the US market. The approval is an outcome…
Read More...

Dr. Donna Morgan Murray has been appointed as Nativis Chief Regulatory Officer with immediate effective. Murray is author of more than 60 publications in peer-referenced…
Read More...

Saneca Pharma announced that after an inspection Russian Federal State Institution ‘State Institute of Drugs and Good Practices’ has granted them multi-dosage cGMP certificate. cGMP…
Read More...

MilliporeSigma announced that SystImmune has selected its CHOZN Expression System for commercial development of a bi-specific antibody therapeutic. The CHOZN expression system is…
Read More...

AVEO Oncology has appointed Matthew Dallas as CFO (chief financial officer) effective from June 1, 2017. Mr. Dallas will be responsible for the Company’s financial strategy and…
Read More...

Cambrex Corporation will invest $2.4M is to expand pilot plant capacity by around 30% at its High Point, NC facility with the installation of a fourth reactor suite. The new 400 sq.…
Read More...

Halo Pharma announces the formation of its Pediatric Center of Excellence in support of the development and manufacture of dosage forms tailored for pediatric indications. Halo Pharma…
Read More...

Bristol-Myers Squibb (BMS) and Calithera Biosciences expanded their collaboration to evaluate BMS’s Opdivo in combination with Calithera’s CB-839 in patients with non-small cell lung…
Read More...

NOXXON Pharma signed an agreement with the National Center for Tumor Diseases (NCT) in Heidelberg. Under the agreement NCT will conduct a trial evaluating NOXXON’s lead product…
Read More...

AMAG Pharmaceuticals announced that Helen Milton has been appointed as AMAG's Regulatory Affairs vice president. She will be responsible for regulatory activities along with company’s…
Read More...

Synlogic announced that it has entered into a definitive merger agreement with a wholly owned subsidiary of Mirna in an all-stock transaction and will continue under the Synlogic name.…
Read More...

Catalent Pharma Solutions announced that it has collaborated with Therachon AG to support preclinical and clinical development of TA-46. TA-46 is a novel protein addressing…
Read More...

Thermo Fisher Scientific and Patheon together announced that their boards of directors have approved Thermo Fisher's acquisition of Patheon at a price of $7.2 billion. Thermo Fisher…
Read More...

Upon the approval from the FDA to sell vadadustat to Fresenius Medical Care dialysis clinics in the US, Akebia Therapeutics and Vifor Pharma Group entered into an exclusive license…
Read More...

Patheon announced that with an investment of $26 million it has updated sterile Pharmaceutical Development Services (PDS) suites at its Greenville, NC manufacturing site. The PDS Suites…
Read More...